natgillin/translations-raw huggingface dataset:
Merckle GmbH Ludvig-Merckle-Strasse 3 89143 Blaubeuren Tyskland
Merckle GmbH Ludwig-Merckle-Strasse 3 89143 Blaubeuren Germany
Sikkerhed og effekt er ikke undersøgt ved samtidig brug af sildenafil og andre PDE5-hæmmere eller andre behandlinger af erektil dysfunktion eller ved samtidig sildenafil-behandling af pulmonal arteriel hypertension (PAH).
The safety and efficacy of combinations of sildenafil with other PDE5 Inhibitors, or other pulmonary arterial hypertension (PAH) treatments containing sildenafil, or other treatments for erectile dysfunction have not been studied.
Hos frivillige forsøgspersoner med let til moderat levercirrhose (Child-Pugh A og B) reduceres sildenafils clearance, hvilket giver stigninger i AUC (84%) og Cmax (47%) sammenlignet med frivillige forsøgspersoner i samme alderskategori uden leverinsufficiens.
In volunteers with mild to moderate hepatic cirrhosis (Child-Pugh A and B) sildenafil clearance was reduced, resulting in increases in AUC (84%) and Cmax (47%) compared to age-matched volunteers with no hepatic impairment.
Følg lægens ordination og tag 1 filmovertrukket tablet Sildenafil ratiopharm ca. 1 time før seksuel aktivitet.
Take 1 film-coated tablet of Sildenafil ratiopharm about 1 hour before sexual activity.
Dosering Voksne
Posology Use in adults
Samtidig administration af sildenafil hos patienter, der er i alfa-blokker-behandling, kan hos få følsomme individer føre til symptomatisk hypotension.
Concomitant administration of sildenafil to patients taking alpha-blocker therapy may lead to symptomatic hypotension in a few susceptible individuals.
De hyppigst rapporterede bivirkninger i kliniske studier hos sildenafilbehandlede patienter var hovedpine, ansigtsrødme, dyspepsi, næsetilstopning, svimmelhed, kvalme, hedeture, synsforstyrrelser, cyanopsi (blåsyn) og sløret syn.
The most commonly reported adverse reactions in clinical studies among sildenafil treated patients were headache, flushing, dyspepsia nasal congestion, dizziness, nausea, hot flush, visual disturbance, cyanopsia and vision blurred.
Alvorlige hudreaktioner- dette ses sjældent.
- Serious skin reactions - this occurs rarely.
- ritonavir eller saquinavir (medicin til behandling af hiv-infektioner); - ketoconazol eller itraconazol (medicin til behandling af svampeinfektioner); - erythromycin (et antibiotikum); - cimetidin (medicin til behandling af halsbrand og mavesår);
Therefore, tell your doctor if you are taking any of the following medicines: - ritonavir or saquinavir (medicines for the treatment of HIV infections); - ketoconazole or itraconazole (medicines for the treatment of fungal infections); - erythromycin (an antibiotic); - cimetidine (medicine for the treatment of heartburn and peptic ulcers);
Forstyrrelser i tåredannelsen***, øjensmerter, fotofobi, fotopsi, okulær hyperæmi, lysglimt, konjunktivitis
Lacrimation disorders***, Eye pain, Photophobia, Photopsia, Ocular hyperaemia, Visual brightness, Conjunctivitis
Hos frivillige forsøgspersoner med svært nedsat nyrefunktion (kreatininclearance < 30 ml/min) reduceres sildenafil-clearance, hvilket fører til gennemsnitlige stigninger i AUC og Cmax på henholdsvis 100% og 88% sammenlignet med forsøgspersoner i samme alderskategori uden nedsat nyrefunktion.
In volunteers with severe renal impairment (creatinine clearance < 30 mL/min), sildenafil clearance was reduced, resulting in mean increases in AUC and Cmax of 100% and 88% respectively compared to age-matched volunteers with no renal impairment.
Merckle GmbH Ludwig-Merckle-Straße 3 89143 Blaubeuren Tyskland
Manufacturer Merckle GmbH Ludwig-Merckle-Straße 3 89143 Blaubeuren Germany
Der var ingen effekt på spermiemotilitet eller -morfologi efter indgift af en enkelt oral dosis sildenafil 100 mg hos raske forsøgspersoner (se pkt.
There was no effect on sperm motility or morphology after single 100 mg oral doses of sildenafil in healthy volunteers (see section 4.6).
Croscarmellosenatrium Calciumhydrogenphosphat (vandfrit) Talcum
Calcium hydrogen phosphate, anhydrous Talc
4.4 og 4.5).
8, 9, 10 and 11.
Jernoxid, rød
Iron oxide red
Der er spontane rapporter om synsdefekter i forbindelse med indtagelse af sildenafil og andre PDE5hæmmere (se pkt.
Cases of visual defects have been reported spontaneously in connection with the intake of sildenafil and other PDE5 inhibitors (see section 4.8).
Kramper eller krampeanfald - dette ses sjældent.
- Seizures or fits - this occurs rarely.
I et studie med raske, frivillige mænd resulterede samtidig administration af endothelinantagonisten bosentan (en induktor af CYP3A4 (moderat), CYP2C9 og muligvis CYP2C19) ved steady state (125 mg 2 gange daglig) og sildenafil ved steady state (80 mg 3 gange daglig) i en reduktion i AUC og Cmax på henholdsvis 62,6% og 55,4%.
In a study of healthy male volunteers, co-administration of the endothelin antagonist, bosentan, (an inducer of CYP3A4 [moderate], CYP2C9 and possibly of CYP2C19) at steady state (125 mg twice a day) with sildenafil at steady state (80 mg three times a day) resulted in 62.6% and 55.4% decrease in sildenafil AUC and Cmax, respectively.
Initiering af sildenafil i en dosis på 25 mg bør overvejes (se pkt.
Initiation of sildenafil at a dose of 25 mg should be considered (see section 4.2).
Sildenafil er en oral behandling af erektil dysfunktion, som genopretter nedsat erektil funktion ved at øge blodtilstrømningen til penis på en naturlig måde ved seksuel stimulation.
In the natural setting, i.e. with sexual stimulation, it restores impaired erectile function by increasing blood flow to the penis.
Blødning fra penis, priapisme*, hæmatospermi, forlænget erektion
Penile haemorrhage, Priapism*, Haematospermia, Erection increased
Sildenafils metabolisme sker overvejende via CYP isoformer 3A4 (primær vej) og 2C9 (sekundær vej).
Sildenafil metabolism is principally mediated by the cytochrome P450 (CYP) isoforms 3A4 (major route) and 2C9 (minor route).
Myalgi, ekstremitetssmerter
Myalgia, Pain in extremity
Brug af anden medicin sammen med Sildenafil ratiopharm
Other medicines and Sildenafil ratiopharm
Seksuel stimulation er nødvendig, for at sildenafil kan virke.
In order for sildenafil to be effective, sexual stimulation is required.
Synsfarveforvrængning**, synsforstyrrelser, sløret syn
Visual colour distortions**, Visual disturbance, Vision blurred
(≥ 1/100 og <1/10)
(≥ 1/100 and
Samtidig indgift af sildenafil og ritonavir anbefales ikke (se pkt.
Co-administration of sildenafil with ritonavir is not advised (see section 4.5).
Ved indgift af en enkeltdosis sildenafil 100 mg sammen med erythromycin, en moderat CYP3A4hæmmer, i steady state (500 mg 2 gange dagligt i 5 dage) sås en 182% stigning i optagelsen af sildenafil (AUC).
When a single 100 mg dose of sildenafil was administered with erythromycin, a moderate CYP3A4 inhibitor, at steady state (500 mg twice daily for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC).
Følg lægens ordination og tag ½ eller 1 filmovertrukket tablet Sildenafil ratiopharm ca. 1 time før seksuel aktivitet.
Take ½ or 1 film-coated tablet of Sildenafil ratiopharm as prescribed by your doctor about 1 hour before sexual activity.
EU/1/09/603/009 1 filmovertrukket tablet EU/1/09/603/010 4 filmovertrukne tabletter EU/1/09/603/011 8 filmovertrukne tabletter EU/1/09/603/012 12 filmovertrukne tabletter EU/1/09/603/015 2 filmovertrukne tabletter EU/1/09/603/016 24 filmovertrukne tabletter EU/1/09/603/018 48 filmovertrukne tabletter
EU/1/09/603/009 1 film-coated tablet EU/1/09/603/010 4 film-coated tablets EU/1/09/603/011 8 film-coated tablets EU/1/09/603/012 12 film-coated tablets EU/1/09/603/015 2 film-coated tablets EU/1/09/603/016 24 film-coated tablets EU/1/09/603/018 48 film-coated tablets
Efter enten oral eller intravenøs indgift udskilles sildenafil som metabolitter hovedsageligt i faeces (ca. 80% af indgivet oral dosis) og i mindre grad i urinen (ca. 13% af indgivet oral dosis).
The total body clearance of sildenafil is 41 L/h with a resultant terminal phase half-life of 3-5 h. After either oral or intravenous administration, sildenafil is excreted as metabolites predominantly in the faeces (approximately 80% of administered oral dose) and to a lesser extent in the urine (approximately 13% of administered oral dose).
I et dobbelt-blindt, placebo-kontrolleret motionsstressstudie, hvori 144 patienter med erektil dysfunktion og stabil angina tog deres sædvanlige medicin mod angina pectoris (undtaget nitrater), blev der ikke set klinisk relevante forskelle i tiden indtil angina blev en begrænsende faktor for sildenafil sammenlignet med placebo.
A double-blind, placebo-controlled exercise stress trial evaluated 144 patients with erectile dysfunction and chronic stable angina who regularly received anti-anginal medicinal products (except nitrates).
Sådan skal du tage Sildenafil ratiopharm
How to take Sildenafil ratiopharm
DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE/FORNYELSE AF TILLADELSEN
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 23 December 2009.
Hos raske frivillige forsøgspersoner gav cimetidin (800 mg), en cytokrom P450-hæmmer og ikke specifik CYP3A4-hæmmer en 56% stigning i plasmakoncentrationer af sildenafil ved indgift sammen med sildenafil (50 mg).
Cimetidine (800 mg), a cytochrome P450 inhibitor and non-specific CYP3A4 inhibitor, caused a 56% increase in plasma sildenafil concentrations when co-administered with sildenafil (50 mg) to healthy volunteers.
Spørg lægen eller på apoteket, hvis du er i tvivl.
Check with your doctor or pharmacist if you are not sure.
Sildenafil ratiopharm 25 mg filmovertrukne tabletter Hvid til off-white, aflang, filmovertrukket tablet med kant.
Sildenafil ratiopharm 25 mg film-coated tablets White to off-white, oblong film-coated tablet with edge.
Øget hjerterytme
Heart rate increased
Almindelig (kan ses hos op til 1 ud af 10 personer): kvalme, ansigtsrødme, hedeture (symptomerne omfatter en pludselig varmefølelse i overkroppen), dårlig fordøjelse, farvesyn, sløret syn, synsforstyrrelser, tilstoppet næse og svimmelhed.
Common (may affect up to 1 in 10 people): nausea, facial flushing, hot flush (symptoms include a sudden feeling of heat in your upper body), indigestion, colour tinge to vision, blurred vision, visual disturbance, stuffy nose and dizziness.
Lad være med at arbejde med værktøj eller maskiner, hvis du føler dig svimmel, eller dit syn eller din hørelse påvirkes efter indtagelse af Sildenafil ratiopharm.
If you feel dizzy, or if your vision or hearing is affected after taking Sildenafil ratiopharm, do not drive or operate any tools or machines.
Sildenafil er kontraindiceret til patienter, som på grund af non-arteritis anterior iskæmisk opticusneuropati (NAION) har nedsættelse af synet på det ene øje.
Sildenafil is contraindicated in patients who have loss of vision in one eye because of non-arteritic anterior ischaemic optic neuropathy (NAION), regardless of whether this episode was in connection or not with previous PDE5 inhibitor exposure (see section 4.4).
Sjælden (kan ses hos op til 1 ud af 1.000 personer): besvimelse, slagtilfælde, hjerteanfald, uregelmæssig hjerterytme, midlertidigt nedsat blodtilførsel til dele af hjernen, følelse af, at halsen snører sig sammen, følelsesløshed i munden, blødninger i den bagerste del af øjet, dobbeltsyn, nedsat synsskarphed, unormal følelse i øjet, hævede øjne eller øjenlåg, små partikler eller pletter i synsfeltet, se en farvet ring omkring lyskilder, forstørrede pupiller, misfarvning af det hvide i øjet, blødning fra penis, blod i sæden, næsetørhed, hævelse inde i næsen, følelse af irritation og pludselig hørenedsættelse eller høretab.
Rare (may affect up to 1 in 1,000 people): fainting, stroke, heart attack, irregular heartbeat, temporary decreased blood flow to parts of the brain, feeling of tightening of the throat, numb mouth, bleeding at the back of the eye, double vision, reduced sharpness of vision, abnormal sensation in the eye, swelling of the eye or eyelid, small particles or spots in your vision, seeing halos around lights, dilation of the pupil of the eye, discolouration of the white of the eye, penile bleeding, presence of blood in semen, dry nose, swelling of the inside of the nose, feeling irritable and sudden decrease or loss of hearing.
Smerter i brystet - dette ses ikke almindeligt.
- Chest pains - this occurs uncommonly.
Sildenafil ratiopharm 25 mg filmovertrukne tabletter EU/1/09/603/001
Sildenafil ratiopharm 25 mg film-coated tablets EU/1/09/603/001
Gennemsnitlig AUC og Cmax af N-desmethylmetabolitten øges med henholdsvis op til 126% og op til 73% sammenlignet med frivillige forsøgspersoner med samme alder uden nedsat nyrefunktion.
The mean AUC and Cmax of the N-desmethyl metabolite increased up to 126% and up to 73% respectively,
Efter markedsføringen er der i forbindelse med brugen af sildenafil rapporteret alvorlige kardiovaskulære hændelser, inklusiv myokardieinfarkt, ustabil angina pectoris, pludselig hjertedød, ventrikulær arytmi, cerebrovaskulær blødning, transitorisk cerebral iskæmi, hypertension og hypotension.
Serious cardiovascular events, including myocardial infarction, unstable angina, sudden cardiac death, ventricular arrhythmia, cerebrovascular haemorrhage, transient ischaemic attack, hypertension and hypotension have been reported post-marketing in temporal association with the use of sildenafil.
1 filmovertrukket tablet 2 filmovertrukne tabletter 4 filmovertrukne tabletter 8 filmovertrukne tabletter 12 filmovertrukne tabletter 24 filmovertrukne tabletter 48 filmovertrukne tabletter
1 film-coated tablet 2 film-coated tablets 4 film-coated tablets 8 film-coated tablets 12 film-coated tablets 24 film-coated tablets 48 film-coated tablets
Sildenafil ratiopharm 100 mg filmovertrukne tabletter EU/1/09/603/009
Sildenafil ratiopharm 100 mg film-coated tablets EU/1/09/603/009
EU/1/09/603/005 1 filmovertrukket tablet EU/1/09/603/006 4 filmovertrukne tabletter EU/1/09/603/007 8 filmovertrukne tabletter EU/1/09/603/008 12 filmovertrukne tabletter EU/1/09/603/014 2 filmovertrukne tabletter EU/1/09/603/017 24 filmovertrukne tabletter
EU/1/09/603/005 1 film-coated tablet EU/1/09/603/006 4 film-coated tablets EU/1/09/603/007 8 film-coated tablets EU/1/09/603/008 12 film-coated tablets EU/1/09/603/014 2 film-coated tablets EU/1/09/603/017 24 film-coated tablets
Samtidig indgift af HIV-proteasehæmmeren ritonavir, som er en meget potent CYP-hæmmer, ved steady state (500 mg 2 gange dagligt) og enkeltdosis af sildenafil (100 mg) gav en stigning i sildenafils Cmax på 300% (4 gange) og en stigning i sildenafils plasma-AUC på 1.000% (11 gange).
Co-administration of the HIV protease inhibitor ritonavir, which is a highly potent P450 inhibitor, at steady state (500 mg twice daily) with sildenafil (100 mg single dose) resulted in a 300% (4-fold) increase in sildenafil Cmax and a 1,000% (11-fold) increase in sildenafil plasma AUC.
Da sildenafil-clearance er nedsat hos patienter med alvorligt nedsat nyrefunktion (kreatininclearance < 30 ml/min.)
Since sildenafil clearance is reduced in patients with severe renal impairment (creatinine clearance < 30 mL/min), a 25 mg dose should be considered.
Sildenafil ratiopharm 50 mg filmovertrukne tabletter EU/1/09/603/005
Sildenafil ratiopharm 50 mg film-coated tablets EU/1/09/603/005
5.1) er det vist, at sildenafil potenserer nitraters hypotensive effekt, hvorfor indgift sammen med nitrogenoxiddonorer (som amylnitrit) eller enhver form for nitrater derfor er kontraindiceret.
Consistent with its known effects on the nitric oxide/cyclic guanosine monophosphate (cGMP) pathway (see section 5.1), sildenafil was shown to potentiate the hypotensive effects of nitrates, and its co-administration with nitric oxide donors (such as amyl nitrite) or nitrates in any form is therefore contraindicated.
EU/1/09/603/001 1 filmovertrukket tablet EU/1/09/603/002 4 filmovertrukne tabletter EU/1/09/603/003 8 filmovertrukne tabletter EU/1/09/603/004 12 filmovertrukne tabletter EU/1/09/603/013 2 filmovertrukne tabletter
EU/1/09/603/001 1 film-coated tablet EU/1/09/603/002 4 film-coated tablets EU/1/09/603/003 8 film-coated tablets EU/1/09/603/004 12 film-coated tablets EU/1/09/603/013 2 film-coated tablets
Samtidig indgift af HIV-proteasehæmmeren saquinavir, en CYP3A4-hæmmer, ved steady state (1.200 mg 3 gange dagligt) og enkeltdosis sildenafil (100 mg) gav en stigning i sildenafils Cmax på 140% og en stigning i sildenafils plasma-AUC på 210%.
Co-administration of the HIV protease inhibitor saquinavir, a CYP3A4 inhibitor, at steady state (1200 mg three times a day) with sildenafil (100 mg single dose) resulted in a 140% increase in sildenafil Cmax and a 210% increase in sildenafil AUC.
4.4) og den samlede dosis for sildenafil bør under ingen omstændigheder overstige 25 mg inden for 48 timer.
Based on these pharmacokinetic results co-administration of sildenafil with ritonavir is not advised (see section 4.4) and in any event the maximum dose of sildenafil should under no circumstances exceed 25 mg within 48 hours.
1 filmovertrukket tablet 2 filmovertrukne tabletter 4 filmovertrukne tabletter 8 filmovertrukne tabletter 12 filmovertrukne tabletter
1 film-coated tablet 2 film-coated tablets 4 film-coated tablets 8 film-coated tablets 12 film-coated tablets
Det skal du vide, før du begynder at tage Sildenafil ratiopharm Sådan skal du tage Sildenafil ratiopharm Bivirkninger
What Sildenafil ratiopharm is and what it is used for What you need to know before you take Sildenafil ratiopharm How to take Sildenafil ratiopharm Possible side effects
For at nedsætte sandsynligheden for, at du får disse symptomer, må du først starte med at tage Sildenafil ratiopharm, når dit blodtryk er velkontrolleret med en regelmæssig daglig dosis af alfablokkeren.Lægen kan give dig den laveste begyndelsesdosis (25 mg) af Sildenafil ratiopharm, hvis du tager en af ovenstående medicintyper.
In order to reduce the probability of these symptoms occurring, you should start taking Sildenafil ratiopharm only when you are already well controlled on a regular daily dose of your alpha blocker.
Det er mest sandsynligt, at dette indtræder inden for 4 timer efter indtagelse af sildenafildosen (se pkt.
This is most likely to occur within 4 hours post sildenafil dosing (see sections 4.2 and 4.4).
Ikke almindelig (kan ses hos op til 1 ud af 100 personer): opkastning, hududslæt, øjenirritation, blodsprængte øjne/røde øjne, smerte i øjet, forskellige lysfornemmelser, f.eks. lysflimren og lysglimt, lysfølsomhed, rindende øjne, uregelmæssig eller hurtig puls, forhøjet blodtryk, lavt blodtryk, muskelsmerter, føle sig søvnig, nedsat følelse ved berøring, svimmelhed, susen for ørerne (tinnitus), mundtørhed, blokerede eller tilstoppede bihuler, irritation i næseslimhinden (symptomerne omfatter løbende næse, nysen og tilstoppet næse), mavesmerter lige over navlen, gastroøsofageal reflukssyndrom (tilbageløb af syre fra mavesækken til spiserøret - symptomerne omfatter halsbrand), blod i urinen, smerter i arme og ben, næseblod, varmefølelse og træthed.
Uncommon (may affect up to 1 in 100 people): vomiting, skin rash, eye irritation, bloodshot eyes/red eyes, eye pain, seeing flashes of light, visual brightness, light sensitivity, watery eyes, pounding heartbeat, rapid heartbeat, high blood pressure, low blood pressure, muscle pain, feeling sleepy, reduced sense of touch, vertigo, ringing in the ears, dry mouth, blocked or stuffy sinuses, inflammation of the lining of the nose (symptoms include runny nose, sneezing and stuffy nose), upper abdominal pain, gastro-oesophageal reflux disease (symptoms include heartburn), presence of blood in urine, pain in the arms or legs, nosebleed, feeling hot and feeling tired.
1 filmovertrukket tablet 2 filmovertrukne tabletter 4 filmovertrukne tabletter 8 filmovertrukne tabletter 12 filmovertrukne tabletter 24 filmovertrukne tabletter
1 film-coated tablet 2 film-coated tablets 4 film-coated tablets 8 film-coated tablets 12 film-coated tablets 24 film-coated tablets
Udseende og pakningsstørrelser Sildenafil ratiopharm er hvide til off-white, aflange filmovertrukne tabletter med kant.
What Sildenafil ratiopharm looks like and contents of the pack Sildenafil ratiopharm are white to off-white, oblong film-coated tablets with edge.
Derudover bør en initialdosis af sildenafil på 25 mg overvejes (se pkt.
In addition, initiation of sildenafil at a dose of 25 mg should be considered (see sections 4.4 and 4.5).
Hos raske, frivillige mænd forårsagede sildenafil ved steady state (80 mg 3 gange daglig) en stigning i bosentan-AUC på 49,8% og en stigning i Cmax af bosentan på 42% (125 mg 2 gange daglig).
resulted in a 49.8% increase in bosentan AUC and a 42% increase in bosentan Cmax (125 mg b.i.d.
”blodprop i øjet” (non-arteritis anterior iskæmisk opticusneuropati (NAION)).
- if you have ever suffered from loss of vision due to an eye condition known as “stroke of the eye” (non-arteritic anterior ischaemic optic neuropathy, NAION).
INFORMATION I BRAILLESKRIFT Sildenafil ratiopharm 25 mg
INFORMATION IN BRAILLE Sildenafil ratiopharm 25 mg
INFORMATION I BRAILLESKRIFT Sildenafil ratiopharm 100 mg
INFORMATION IN BRAILLE Sildenafil ratiopharm 100 mg
- hvis du samtidig bliver behandlet for pulmonal arteriel hypertension (PAH) med et lægemiddel,
- if you are already undergoing treatments for pulmonary arterial hypertension (PAH) containing sildenafil or any other PDE5 inhibitors.
INFORMATION I BRAILLESKRIFT Sildenafil ratiopharm 50 mg
INFORMATION IN BRAILLE Sildenafil ratiopharm 50 mg
Sildenafil ratiopharm 100 mg filmovertrukne tabletter Hver filmovertrukket tablet indeholder sildenafilcitrat svarende til 100 mg sildenafil.
Sildenafil ratiopharm 100 mg film-coated tablets Each film-coated tablet contains sildenafil citrate equivalent to 100 mg of sildenafil.
Gastroøsofagal refluksyndrom, opkastning, smerter i øvre abdomen, mundtørhed
Gastro oesophagael reflux disease, Vomiting, Abdominal pain upper,
Sildenafil ratiopharm 25 mg filmovertrukne tabletter Pakningsstørrelser på 1, 2, 4, 8 eller 12 filmovertrukne tabletter.
Sildenafil ratiopharm 25 mg film-coated tablets Pack sizes of 1, 2, 4, 8, or 12 film-coated tablets.
Sildenafil ratiopharm indeholder:
What Sildenafil ratiopharm is
Sildenafil ratiopharm 25 mg filmovertrukne tabletter Hver filmovertrukket tablet indeholder sildenafilcitrat svarende til 25 mg sildenafil.
Sildenafil ratiopharm 25 mg film-coated tablets Each film-coated tablet contains sildenafil citrate equivalent to 25 mg of sildenafil.
Sildenafil ratiopharm 50 mg filmovertrukne tabletter Pakningsstørrelser på 1, 2, 4, 8, 12 eller 24 filmovertrukne tabletter.
Sildenafil ratiopharm 50 mg film-coated tablets Pack sizes of 1, 2, 4, 8, 12 or 24 film-coated tablets.
Udslæt
Haematuria
4.4) bør en startdosis på 25 mg overvejes til patienter i samtidig behandling med andre CYP3A4-hæmmere (se pkt.
With the exception of ritonavir for which co-administration with sildenafil is not advised (see section 4.4), a starting dose of 25 mg should be considered in patients receiving concomitant treatment with CYP3A4 inhibitors (see section 4.5).
Sildenafil ratiopharm 50 mg filmovertrukne tabletter Hver filmovertrukket tablet indeholder sildenafilcitrat svarende til 50 mg sildenafil.
Sildenafil ratiopharm 50 mg film-coated tablets Each film-coated tablet contains sildenafil citrate equivalent to 50 mg of sildenafil.
Cerebrovaskulær hændelse, transitorisk iskæmisk attak, krampeanfald*, tilbagevendende krampeanfald*, synkope
Retinal haemorrhage, Arteriosclerotic retinopathy, Retinal disorder, Glaucoma,
Sildenafil ratiopharm 25 mg filmovertrukne tabletter
Sildenafil ratiopharm 25 mg film-coated tablets
Sildenafil ratiopharm 100 mg filmovertrukne tabletter
Sildenafil ratiopharm 100 mg film-coated tablets
Sildenafil ratiopharm leveres i pakningsstørrelser med 1, 2, 4, 8, 12, 24 eller 48 filmovertrukne tabletter i blisterpakninger.
Sildenafil ratiopharm are supplied in packs of 1, 2, 4, 8, 12, 24 or 48 film-coated tablets in blisters.
Sammensnøret hals, næseødem, tørhed i næsen
Throat tightness, Nasal oedema, Nasal dryness
Sildenafil ratiopharm leveres i pakningsstørrelser med 1, 2, 4, 8 eller 12 filmovertrukne tabletter i blisterpakninger.
Sildenafil ratiopharm are supplied in packs of 1, 2, 4, 8 or 12 film-coated tablets in blisters.